Whole-genome association studies of sporadic amyotrophic lateral sclerosis: are retroelements involved?

Trends in Molecular Medicine

Volumn 15, Issue 4, 2009, Pages 148-158

  Mougeot, Jean Luc ^a   Richardson Milazi, Stephanie ^a   Brooks, Benjamin Rix ^b  

^a CAROLINAS MEDICAL CENTER   (United States)

^b Department of Neurology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; ENZYME ACTIVITY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; PATHOGENESIS; RETROPOSON; SINGLE NUCLEOTIDE POLYMORPHISM;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROELEMENTS;

EID: 63449132990     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2009.02.005     Document Type: Article

References (77)

1. Logroscino G., et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J. Neurol. Neurosurg. Psychiatry 79 (2008) 6-11
2. Beghi E., et al. The epidemiology of ALS and the role of population-based registries. Biochim. Biophys. Acta 1762 (2006) 1150-1157
3. Corcia P., and Meininger V. Management of amyotrophic lateral sclerosis. Drugs 68 (2008) 1037-1048
4. Valdmanis P.N., and Rouleau G.A. Genetics of familial amyotrophic lateral sclerosis. Neurology 70 (2008) 144-152
5. Brown Jr. R.H. SOD1 aggregates in ALS: cause, correlate or consequence?. Nat. Med. 4 (1998) 1362-1364
6. Shaw P.J. Molecular and cellular pathways of neurodegeneration in motor neurone disease. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1046-1057
7. Dimos J.T., et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321 (2008) 1218-1221
8. Wichterle, H. and Peljto, M. (2008) Differentiation of mouse embryonic stem cells to spinal motor neurons. Curr Protoc. Stem Cell Biol., Chapter 1, Unit 1H.1.1-1H.1.9
9. Garber K. Genetics. The elusive ALS genes. Science 319 (2008) 20
10. Valdmanis P.N., et al. Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden. Neurology 71 (2008) 514-520
11. Sleegers K., et al. Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology 71 (2008) 253-259
12. Kabashi E., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40 (2008) 572-574
13. Daoud H., et al. Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J. Med. Genet. 46 (2009) 112-114
14. Kasperaviciute D., et al. Large-scale pathways-based association study in amyotrophic lateral sclerosis. Brain 130 (2007) 2292-2301
15. Blauw H.M., et al. Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen. Lancet Neurol. 7 (2008) 319-326
16. Cronin S., et al. A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum. Mol. Genet. 17 (2008) 768-774
17. Dunckley T., et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N. Engl. J. Med. 357 (2007) 775-788
18. van Es M.A., et al. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol. 6 (2007) 869-877
19. Cronin S., et al. Screening for replication of genome-wide SNP associations in sporadic ALS. Eur. J. Hum. Genet. 17 (2008) 213-218
20. Cronin S., et al. Analysis of genome-wide copy number variation in Irish and Dutch ALS populations. Hum. Mol. Genet. 17 (2008) 3392-3398
21. Schymick J.C., et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol. 6 (2007) 322-328
22. van Es M.A., et al. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat. Genet. 40 (2008) 29-31
23. MacGowan D.J., et al. A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS. Neurology 68 (2007) 1944-1946
24. Steele A.J., et al. Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology 64 (2005) 454-458
25. Andrews W.D., et al. Detection of reverse transcriptase activity in the serum of patients with motor neurone disease. J. Med. Virol. 61 (2000) 527-532
26. McCormick A.L., et al. Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology 70 (2008) 278-283
27. Callinan P.A., and Batzer M.A. Retrotransposable elements and human disease. Genome Dyn. 1 (2006) 104-115
28. Volff J.N., and Brosius J. Modern genomes with retro-look: retrotransposed elements, retroposition and the origin of new genes. Genome Dyn. 3 (2007) 175-190
29. Cousineau B., et al. Retrotransposition of a bacterial group II intron. Nature 404 (2000) 1018-1021
30. Kim F.J., et al. Emergence of vertebrate retroviruses and envelope capture. Virology 318 (2004) 183-191
31. Burghes A.H., and Butchbach M.E. Let all DNA vote: who are the amyotrophic lateral sclerosis candidates?. Neurology 70 (2008) 662-663
32. Dupre N., and Valdmanis P. Genome-wide association studies in amyotrophic lateral sclerosis. Eur. J. Hum. Genet. 17 (2009) 137-138
33. Contreras-Galindo R., et al. HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res. Hum. Retroviruses 23 (2007) 116-122
34. Stengel A., et al. Prion infection influences murine endogenous retrovirus expression in neuronal cells. Biochem. Biophys. Res. Commun. 343 (2006) 825-831
35. Kristensson K. Potential role of viruses in neurodegeneration. Mol. Chem. Neuropathol. 16 (1992) 45-58
36. Manuelidis L. Dementias, neurodegeneration, and viral mechanisms of disease from the perspective of human transmissible encephalopathies. Ann. N. Y. Acad. Sci. 724 (1994) 259-281
37. Gardner M.B., et al. A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. J. Natl. Cancer Inst. 51 (1973) 1243-1254
38. Jolicoeur P., et al. Molecular cloning of infectious viral DNA from ecotropic neurotropic wild mouse retrovirus. J. Virol. 45 (1983) 1159-1163
39. Zachary J.F., et al. Mouse Moloney leukemia virus infects microglia but not neurons even though it induces motor neuron disease. Mol. Psychiatry 2 (1997) 104-106
40. Robertson S.J., et al. Neurologic disease induced by polytropic murine retroviruses: neurovirulence determined by efficiency of spread to microglial cells. J. Virol. 71 (1997) 5287-5294
41. Nagai M., and Osame M. Human T-cell lymphotropic virus type I and neurological diseases. J. Neurovirol. 9 (2003) 228-235
42. Machigashira N., et al. HTLV-1-associated myelopathy/tropical spastic paraparesis with pseudohypoparathyroidism. Neurology 56 (2001) 104-106
43. Haase A.T. Viral gene expression and pathogenesis in three emerging diseases: HIV and AIDS; HTLV-I and HAM/TSP; and HHV-8 and Kaposi's sarcoma. FEMS Immunol. Med. Microbiol. 18 (1997) 301-305
44. Izumo S. Retrovirus infection and neurological disorders. Rinsho Shinkeigaku 45 (2005) 815-817
45. Berrada F., et al. Neuronal expression of human immunodeficiency virus type 1 env proteins in transgenic mice: distribution in the central nervous system and pathological alterations. J. Virol. 69 (1995) 6770-6778
46. Antony J.M., et al. The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes. J. Immunol. 179 (2007) 1210-1224
47. Viola M.V., et al. RNA-instructed DNA polymerase activity in a cytoplasmic particulate fraction in brains from Guamanian patients. J. Exp. Med. 142 (1975) 483-494
48. MacGowan D.J., et al. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 57 (2001) 1094-1097
49. Moulignier A., et al. Reversible ALS-like disorder in HIV infection. Neurology 57 (2001) 995-1001
50. Pearl D., et al. Lower motor neuron syndrome and HIV infection. Sex. Transm. Infect. 79 (2003) 351
51. Sastry L., et al. Product-enhanced reverse transcriptase assay for replication-competent retrovirus and lentivirus detection. Hum. Gene Ther. 16 (2005) 1227-1236
52. Chen C., et al. Association of gag multimers with filamentous actin during equine infectious anemia virus assembly. Curr. HIV Res. 5 (2007) 315-323
53. Jolly C., and Sattentau Q.J. Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains. J. Virol. 81 (2007) 7873-7884
54. Sloane A.J., et al. Marked structural and functional heterogeneity in CXCR4: separation of HIV-1 and SDF-1α responses. Immunol. Cell Biol. 83 (2005) 129-143
55. Jolly C., et al. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 199 (2004) 283-293
56. Lyengar S., and Schwartz D.H. How do cell-free HIV virions avoid infecting dead-end host cells and cell fragments?. AIDS Rev. 6 (2004) 155-160
57. Strong M.J., et al. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol. Cell. Neurosci. 35 (2007) 320-327
58. Guerreiro R.J., et al. TDP-43 is not a common cause of sporadic amyotrophic lateral sclerosis. PLoS One 3 (2008) e2450
59. Lariviere R.C., and Julien J.P. Functions of intermediate filaments in neuronal development and disease. J. Neurobiol. 58 (2004) 131-148
60. Rademakers R., et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum. Mol. Genet. 17 (2008) 3631-3642
61. Pikaart M.J., et al. Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. Genes Dev. 12 (1998) 2852-2862
62. Gaynor, R.B. et al. (1997) Board of Regents, The University of Texas System. Cellular protein TDP-43 and regulation of HIV-1 gene expression, US Patent 5,688,511
63. Ou S.H., et al. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69 (1995) 3584-3596
64. Mellgren A., et al. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection. Neurology 69 (2007) 1536-1541
65. Corcia P., et al. A clustering of conjugal amyotrophic lateral sclerosis in southeastern France. Arch. Neurol. 60 (2003) 553-557
66. Freed E.O., and Mouland A.J. The cell biology of HIV-1 and other retroviruses. Retrovirology 3 (2006) 77
67. Nelson P.N., et al. Demystified. Human endogenous retroviruses. Mol. Pathol. 56 (2003) 11-18
68. Lower R., et al. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 4480-4484
69. Dewannieux M., et al. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res. 16 (2006) 1548-1556
70. Mangeney M., et al. Endogenous retrovirus expression is required for murine melanoma tumor growth in vivo. Cancer Res. 65 (2005) 2588-2591
71. Colmegna I., and Garry R.F. Role of endogenous retroviruses in autoimmune diseases. Infect. Dis. Clin. North Am. 20 (2006) 913-929
72. Christensen T., et al. Expression of sequence variants of endogenous retrovirus RGH in particle form in multiple sclerosis. Lancet 352 (1998) 1033
73. Garson J.A., et al. Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet 351 (1998) 33
74. Mameli G., et al. Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy. J. Neurovirol. 14 (2008) 73-77
75. Oluwole S.O., et al. Elevated levels of transcripts encoding a human retroviral envelope protein (syncytin) in muscles from patients with motor neuron disease. Amyotroph. Lateral Scler. 8 (2007) 67-72
76. Bennett E.A., et al. Natural genetic variation caused by transposable elements in humans. Genetics 168 (2004) 933-951
77. Bacolla A., et al. Long homopurine*homopyrimidine sequences are characteristic of genes expressed in brain and the pseudoautosomal region. Nucleic Acids Res. 34 (2006) 2663-2675